Short-term effects of nocturnal haemodialysis on carnitine metabolism

Nephrology Dialysis Transplantation

Volumn 21, Issue 9, 2006, Pages 2637-2641

  Hothi, Daljit K ^a   Geary, Denis F ^a   Fisher, Lawrence ^a   Chan, Christopher T ^a,b  

^a TORONTO GENERAL HOSPITAL   (Canada)

^b NONE   (Canada)

Author keywords

Carnitine; Metabolism; Nocturnal haemodialysis; Uraemia

Indexed keywords

ACYLCARNITINE; CARNITINE; UREA; BIOLOGICAL FACTOR; DRUG DERIVATIVE;

ADULT; AMINO ACID BLOOD LEVEL; AMINO ACID METABOLISM; ARTICLE; CARNITINE DEFICIENCY; CLINICAL ARTICLE; COHORT ANALYSIS; COLORIMETRY; CONTROLLED STUDY; FEMALE; HEMODIALYSIS; HUMAN; KIDNEY FAILURE; MALE; OBSERVATIONAL STUDY; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; STUDENT T TEST; BLOOD; CHRONIC KIDNEY FAILURE; CIRCADIAN RHYTHM; COMPARATIVE STUDY; DISEASE COURSE; FOLLOW UP; MIDDLE AGED; PHYSIOLOGY; PROGNOSIS; PROSPECTIVE STUDY; RENAL REPLACEMENT THERAPY; TIME;

ADULT; BIOLOGICAL FACTORS; CARNITINE; CIRCADIAN RHYTHM; COLORIMETRY; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDIES; RENAL DIALYSIS; TIME FACTORS;

EID: 33750101041     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfl312     Document Type: Article

References (26)

1. Arduini A, Mancinelli G, Radatti GL, Dottori S, Molajoni F, Ramsay RR. Role of carnitine and carnitine palmitoyltransferase as integral components of the pathway for membrane phospholipid fatty acid turnover in intact human erythrocytes. J Biol Chem 1992; 267: 12673-12681
2. Friedman AN, Bostom AG, Levey AS, Rosenberg IH, Selhub J, Pierratos A. Plasma total homocysteine levels in patients undergoing nocturnal versus standard haemodialysis. J Am Soc Nephrol 2002; 13: 265-268
3. Yuen D, Richardson RM, Fenton SS, McGrath-Chong ME, Chan CT. Quotidian nocturnal haemodialysis improves cytokine profile and enhances erythropoietin responsiveness. ASAIO J 2005; 51: 236-241
4. Bugeja AL, Chan CT. Improvement in lipid profile by nocturnal haemodialysis in patients with end-stage renal disease. ASAIO J 2004; 50: 328-331
5. Evans A. Dialysis-related carnitine disorder and levocarnitine pharmacology. Am J Kidney Dis 2003; 41 [4 Suppl 4]: S13-S26
6. Geary DF, Piva E, Tyrrell J et al. Home nocturnal haemodialysis in children. J Pediatr 2005; 147: 383-387
7. NFK KDOQI Guidelines 2000. Maintenance dialysis - management of acid-base status.
8. Daugirdas JT. Second generation logarithmic estimates of single-pool variable volume Kt/V: An analysis of error. J Am Soc Nephrol 1993; 4: 1205-1213
9. Borah MF, Schoenfeld PY, Gotch FA, Sargent JA, Wolfsen M, Humphreys MH. Nitrogen balance during intermittent dialysis therapy of uremia. Kidney Int 1978; 14: 491-500
10. Maeda J, Dudrick SJ. Rapid spectrophotometric determination of plasma carnitine concentrations. JPEN J Parenter Enteral Nutr 1990; 14: 527-532
11. Fornasini G, Evans AM. Analysis of free carnitine in plasma of ESRD patients undergoing chronic dialysis: What is the best assay? Dial Transplantation 2003; 32 [6 Suppl 1]: S1-S12
12. Marzo A, Arrigoni Martelli E, Mancinelli A et al. Protein binding of L-carnitine family components. Eur J Drug Metab Pharmacokinet 1991; 3: 364-368
13. Rebouche CJ, Lombard KA, Chenard CA. Renal adaptation to dietary carnitine in humans. Am J Clin Nutr 1993; 58: 660-665
14. Bremer J. Pyruvate dehydrogenase, substrate specificity and product inhibition. Eur J Biochem 1969; 8: 535-540
15. Lindsay RM, Alhejaili F, Nesrallah G et al. Calcium and phosphate balance with quotidian haemodialysis. Am J Kidney Dis 2003; 42 [Suppl 1]: 24-29
16. Al-Hejaili F, Kortas C, Leitch R et al. Nocturnal but not short hours quotidian haemodialysis requires an elevated dialysate calcium concentration. J Am Soc Nephrol 2003; 14: 2322-2328
17. Raj DSC, Ouwendyk M, Francoeur R, Pierratos A. Plasma amino acid profile on nocturnal haemodialysis. Blood Purif 2000; 18: 97-102
18. Vaz FM, Wanders RJ. Carnitine biosynthesis in mammals. Biochem J 2002; 361: 417-429
19. Young GA, Parsons FM. Plasma amino acid imbalance in patients with chronic renal failure on intermittent dialysis. Clin Chim Acta 1970; 27: 491-496
20. Brogan LR, Fornasini G, Chace DH, Evans AM. Evaluation of plasma L-carnitine levels in healthy individuals: Comparison of three analytical methods [Abstract]. APSA 2002 (Australasian Pharmaceutical Sciences Association) Conference in Melbourne, Victoria, Australia
21. Stevens RD, Hillman SL, Worthy S, Sanders D, Millington DS. Assay for free and total carnitine in human plasma using tandem mass spectrometry. Clin Chem 2000; 46: 727-729
22. Brass EP. Pharmacokinetic considerations for the therapeutic use of carnitine in haemodialysis patients. Clin Ther 1995; 17: 176-185
23. Eknoyan G, Latos DL, Lindberg J. National Kidney Foundation Carnitine Consensus Conference. Practice recommendations for the use of L-carnitine in dialysis-related carnitine disorder. Am J Kidney Dis 2003; 41: 868-876
24. Schwartz DI, Pierratos A, Richardson RM, Fenton SS, Chan CT. Impact of nocturnal home haemodialysis on anaemia management in patients with end-stage renal disease. Clin Nephrol 2005; 63: 202-208
25. Chan CT, Notarius CF, Merlocco A, Floras JS. Improvement in exercise capacity and duration after conversion to nocturnal haemodialysis. ASN, Philidelphia, PA. J Am Soc Nephrol 2005; 16: 733A
26. Chan CT. Cardiovascular effects of frequent intensive haemo-dialysis. Semin Dial 2004; 17: 99-103